L26/O-290 Disentangling embryo scarcity from reproductive competence in POSEIDON Group 3: a mediation-based analysis of cumulative live birth
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von V. Yakasiri und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Study question In young low-reserve women (POSEIDON Group 3), are poor IVF outcomes driven by impaired reproductive competence or by failure to generate transferable blastocysts? Summary answer Reduced cumulative live birth in POSEIDON Group 3 is primarily mediated by limited blastocyst formation rather than impaired post-transfer reproductive competence. What is known already POSEIDON Group-3 patients are classified as low-prognosis based on reduced ovarian reserve despite young age.Poor outcomes are frequently attributed to impaired implantation or global reproductive incompetence, prompting widespread use of empirical add-on interventions. However,IVF success is the result of a series of biological steps, beginning with oocyte-recruitment and embryo development and culminating in implantation and live birth. Conventional cycle-based reporting does not distinguish between cycles that fail because no transferable embryos are produced and those that fail despite embryo transfer,leading to misinterpretation of prognosis. Whether POSEIDON Group-3 prognosis is predominantly determined by embryo-scarcity or impaired post-transfer reproductive biology remains unclear. Study design, size, duration This retrospective cohort study analysed autologous IVF cycles performed between 2019 and 2024 at a tertiary fertility centre. A total of 3,691 women were classified into POSEIDON Groups 1–4. Primary analyses focused on POSEIDON Group 3 (n = 547) and Group 4 (n = 703), with patient-level cumulative live birth assessed during the study period. Participants/materials, setting, methods All non-PGT autologous IVF cycles with extended blastocyst culture were included. All embryo transfers were frozen embryo transfer cycles using one or two good-quality blastocysts with 100% survival post vitrification–warming. Outcomes were analysed sequentially from stimulation to live birth. Blastocyst formation was modelled as a mediating variable between POSEIDON group and live birth. Odds ratios (OR) with 95% confidence intervals (CI) were calculated. Main results and the role of chance Cycle cancellation due to absence of blastocyst formation occurred significantly less often in POSEIDON Group 3 than in Group 4 (17% vs 38%; OR 0.32, 95% CI 0.25–0.41; p < 0.001). Blastocyst formation rates were higher in Group 3 compared with Group 4 (63% vs 43%; OR 2.26, 95% CI 1.94–2.63; p < 0.001). Patient-level cumulative live birth was significantly higher in Group 3 than Group 4 (36.6% vs 11.4%; OR 4.49, 95% CI 3.36–6.00; p < 0.001), despite similarly reduced ovarian reserve. Among cycles reaching embryo transfer, implantation rates were higher in Group 3 than Group 4 (49% vs 32%; OR 1.31, 95% CI 1.04–1.65; p = 0.02), while miscarriage rates were comparable (7% vs 12%). Despite similarly reduced ovarian reserve, younger age emerged as a key determinant of downstream reproductive competence. POSEIDON Group 3 patients demonstrated significantly higher blastocyst formation, implantation, and cumulative live birth rates than Group 4, indicating that age modifies the biological impact of low ovarian reserve predominantly at the level of embryo developmental potential rather than post-transfer reproductive failure. Limitations, reasons for caution The retrospective design limits causal inference. Embryo genetic competence was not assessed, follow-up duration varied, and the single-centre cohort may limit generalisability. Wider implications of the findings These findings support reframing POSEIDON Group 3 as an embryo-scarcity phenotype. Counselling should focus on expected cycle numbers and time to live birth, prioritising embryo-generation strategies over routine implantation-focused add-ons. Trial registration number Yes
Zitieren
APA
Yakasiri, V., Mantravadi, K., & Gedela, D. (2026). L26/O-290 Disentangling embryo scarcity from reproductive competence in POSEIDON Group 3: a mediation-based analysis of cumulative live birth. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.288
Vancouver
Yakasiri V, Mantravadi K, Gedela D. L26/O-290 Disentangling embryo scarcity from reproductive competence in POSEIDON Group 3: a mediation-based analysis of cumulative live birth. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.288
BibTeX
@article{Yakasiri2026,
author = {Yakasiri, V. and Mantravadi, K.C. and Gedela, D.R.},
title = {L26/O-290 Disentangling embryo scarcity from reproductive competence in POSEIDON Group 3: a mediation-based analysis of cumulative live birth},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.288}
}
EUVIMED